Advertisement

Topics

Sanofi Reports Positive Results From Phase 3 Dupixent Study

08:01 EDT 15 Sep 2018 | FinanzNachrichten

PARIS (dpa-AFX) - Sanofi reported that the detailed results from a Phase 3 trial showed Dupixent (dupilumab) monotherapy demonstrated a significant improvement in signs and symptoms of atopic derm...

Original Article: Sanofi Reports Positive Results From Phase 3 Dupixent Study

NEXT ARTICLE

More From BioPortfolio on "Sanofi Reports Positive Results From Phase 3 Dupixent Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...